Rajesh Pothula

Product Marketing Manager at Clinion      


Rajesh Pothula is a seasoned product marketing manager with a wealth of experience in the eClinical platform industry. He currently works at Clinion, a leading provider of innovative clinical trial management solutions. Rajesh has a deep understanding of the challenges faced by sponsors, CROs, and clinical research professionals, and is committed to helping them overcome these challenges through effective marketing strategies and solutions.

Contributing Author

Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.

Articles from Rajesh

Decentralized Clinical Trials Software’s in 2023: What to Expect

   1793
Decentralized Clinical Trials Software’s in 2023: What to Expect

Healthcare technology is advancing at an unprecedented pace, and the clinical trials industry is no exception. The past few years have seen a steady rise in the adoption of decentralized clinical trials (DCTs) as an alternative to traditional clinical trials, and this trend is expected to continue in 2023 and beyond.

Decentralized clinical trials have gained popularity due to their ability to improve patient access, reduce costs, and accelerate study timelines. DCTs leverage digital technologies to enable patients to participate in clinical trials from the comfort of their own homes or nearby medical facilities, instead of having to travel to a centralized trial site. This has been particularly important during the COVID-19 pandemic, as traditional clinical trials were significantly impacted by lockdowns and social distancing measures.

With the growing need for accelerated drug development, traditional site-centric clinical trial models have evolved to handle consumer requirements during unforeseen events. According to recent data published by the Global data Pharma Intelligence Center, decentralized or remote clinical trials have successfully brought research closer to the patients, with an overall increase of 1.3% of all trials in 2011 to 2.5% in 2020